SML3626
BAY-771
≥98% (HPLC)
别名:
3-(3-(o-Tolyloxy)naphthalen-1-yl)-6-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dione, 3-(4-(2-Methyl-phenoxy)-bicyclo[4.4.0]deca-1(6),2,4,7,9-pentaen-2-yl)-6-(trifluoro-methyl)-1,2,3,4-tetrahydro-pyrimidine-2,4-dione, BAY 069 inactive control, BAY 069 negative control, BAY 771, BAY-069 inactive control, BAY-069 negative control, BAY069 inactive control, BAY069 negative control, BAY771
登录并加购，请在购物车里查看协议价、货期和发货地。
选择规格
变更视图
关于此项目
Assay:
≥98% (HPLC)
Form:
powder
Quality Segment
assay
≥98% (HPLC)
form
powder
color
white to beige
solubility
DMSO: 2 mg/mL, clear
storage temp.
-10 to -25°C
SMILES string
O=C1N(C(C=C(N1)C(F)(F)F)=O)C2=CC(OC3=CC=CC=C3C)=CC4=C2C=CC=C4
InChI key
LZLNIHXKWZZQLE-UHFFFAOYSA-N
Biochem/physiol Actions
BAY-771 is an inactive analog of and a negative control for the potent and selective branched chain amino acid (BCAA) transaminase (BCAT) inhibitor BAY-069 (BCAT1/2 IC50 = 6.5/10.8 μM vs 27/130 nM when using BAY-069).
Inactive analog of and negative control for the potent and selective branched chain amino acid transaminase 1/2 (BCAT1 & BCAT2) inhibitor BAY-069.
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable